2024 Q2 Form 10-Q Financial Statement

#000162828024022767 Filed on May 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $89.21M $70.50M $77.54M
YoY Change -10.87% -9.08% -13.92%
Cost Of Revenue $80.72M $63.28M $70.79M
YoY Change -11.1% -10.61% -13.31%
Gross Profit $8.486M $7.227M $6.755M
YoY Change -8.68% 6.99% -19.85%
Gross Profit Margin 9.51% 10.25% 8.71%
Selling, General & Admin $9.663M $10.20M $10.32M
YoY Change 9563.0% -1.11% -14.15%
% of Gross Profit 113.87% 141.17% 152.72%
Research & Development $1.906M $1.950M $1.290M
YoY Change 17.36% 51.16% -12.48%
% of Gross Profit 22.46% 26.98% 19.1%
Depreciation & Amortization $1.319M $1.480M $1.357M
YoY Change -12.65% 9.06% 27.9%
% of Gross Profit 15.54% 20.48% 20.09%
Operating Expenses $92.84M $76.16M $83.09M
YoY Change -11.01% -8.34% -13.2%
Operating Profit -$671.0K -$5.653M -$5.546M
YoY Change -84.16% 1.93% -1.58%
Interest Expense -$109.0K -$105.0K $16.00K
YoY Change 37.97% -756.25% -1700.0%
% of Operating Profit
Other Income/Expense, Net -$629.0K -$257.0K -$143.0K
YoY Change 657.83% 79.72% -57.57%
Pretax Income -$1.300M -$5.910M -$5.689M
YoY Change -69.91% 3.88% -4.74%
Income Tax -$6.000K $17.00K $12.00K
% Of Pretax Income
Net Earnings -$1.294M -$5.927M -$5.701M
YoY Change -70.22% 3.96% -4.94%
Net Earnings / Revenue -1.45% -8.41% -7.35%
Basic Earnings Per Share -$0.07 -$0.31 -$0.36
Diluted Earnings Per Share -$0.07 -$0.31 -$0.36
COMMON SHARES
Basic Shares Outstanding 20.85M shares 20.78M shares 17.65M
Diluted Shares Outstanding 19.76M shares 19.18M shares 16.01M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.44M $5.682M $6.723M
YoY Change 14.73% -15.48% -77.97%
Cash & Equivalents $10.40M $5.700M $6.700M
Short-Term Investments
Other Short-Term Assets $15.57M $13.61M $8.163M
YoY Change 36.35% 66.75% -29.25%
Inventory
Prepaid Expenses
Receivables $3.919M $2.996M $3.410M
Other Receivables $4.000M $0.00 $0.00
Total Short-Term Assets $33.92M $22.29M $18.30M
YoY Change 36.56% 21.83% -60.41%
LONG-TERM ASSETS
Property, Plant & Equipment $2.015M $2.224M $2.828M
YoY Change -25.56% -21.36% 83.99%
Goodwill $19.34M $25.61M $25.61M
YoY Change -24.46% 0.0% 0.77%
Intangibles $17.42M $23.08M $26.61M
YoY Change -31.79% -13.26% -3.87%
Long-Term Investments
YoY Change
Other Assets $48.00K $50.00K $55.00K
YoY Change -17.24% -9.09% 10.0%
Total Long-Term Assets $46.30M $55.96M $60.27M
YoY Change -21.32% -7.16% 1.57%
TOTAL ASSETS
Total Short-Term Assets $33.92M $22.29M $18.30M
Total Long-Term Assets $46.30M $55.96M $60.27M
Total Assets $80.22M $78.25M $78.57M
YoY Change -4.14% -0.41% -25.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.866M $3.830M $3.987M
YoY Change 3.49% -3.94% -18.52%
Accrued Expenses $2.639M $3.710M $3.814M
YoY Change -24.34% -2.73% -31.59%
Deferred Revenue
YoY Change
Short-Term Debt $10.09M $5.584M $4.477M
YoY Change 34.61% 24.73% -45.15%
Long-Term Debt Due $3.497M $246.0K $1.636M
YoY Change 3542.71% -84.96% 256.43%
Total Short-Term Liabilities $22.29M $17.81M $14.18M
YoY Change 28.06% 25.58% -29.75%
LONG-TERM LIABILITIES
Long-Term Debt $91.00K $3.490M $106.0K
YoY Change -97.34% 3192.45% -29.8%
Other Long-Term Liabilities $344.0K $386.0K $297.0K
YoY Change 12.79% 29.97% -91.95%
Total Long-Term Liabilities $435.0K $3.876M $297.0K
YoY Change 42.62% 1205.05% -92.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.29M $17.81M $14.18M
Total Long-Term Liabilities $435.0K $3.876M $297.0K
Total Liabilities $27.08M $26.32M $19.43M
YoY Change 5.37% 35.45% -19.14%
SHAREHOLDERS EQUITY
Retained Earnings -$78.81M -$77.51M -$53.31M
YoY Change 36.7% 45.41% 105.21%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.14M $51.93M $59.14M
YoY Change
Total Liabilities & Shareholders Equity $80.22M $78.25M $78.57M
YoY Change -4.14% -0.41% -25.57%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.294M -$5.927M -$5.701M
YoY Change -70.22% 3.96% -4.94%
Depreciation, Depletion And Amortization $1.319M $1.480M $1.357M
YoY Change -12.65% 9.06% 27.9%
Cash From Operating Activities -$3.094M -$947.0K -$1.570M
YoY Change -2.31% -39.68% -195.67%
INVESTING ACTIVITIES
Capital Expenditures $670.0K $1.000K $9.000K
YoY Change 108.72% -88.89% -97.16%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $7.305M $0.00
YoY Change -100.0%
Cash From Investing Activities $6.635M -$535.0K -$588.0K
YoY Change -2166.98% -9.01% -77.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $148.0K $318.0K
YoY Change -53.46% -31.91%
Cash From Financing Activities 1.277M -$96.00K 579.0K
YoY Change -78.2% -116.58% -109.18%
NET CHANGE
Cash From Operating Activities -3.094M -$947.0K -1.570M
Cash From Investing Activities 6.635M -$535.0K -588.0K
Cash From Financing Activities 1.277M -$96.00K 579.0K
Net Change In Cash 4.818M -$1.578M -1.579M
YoY Change 103.29% -0.06% -78.43%
FREE CASH FLOW
Cash From Operating Activities -$3.094M -$947.0K -$1.570M
Capital Expenditures $670.0K $1.000K $9.000K
Free Cash Flow -$3.764M -$948.0K -$1.579M
YoY Change 7.91% -39.96% -219.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4601000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3700000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
22290000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
23194000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2224000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2340000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4997000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4150000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23080000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23909000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
25607000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
25607000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58000 usd
CY2024Q1 us-gaap Assets
Assets
78248000 usd
CY2023Q4 us-gaap Assets
Assets
79258000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3830000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3396000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3710000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2681000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
8518000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
8355000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1507000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1504000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
246000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
416000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
17811000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16352000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4630000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3824000 usd
CY2024Q1 fthm Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
3490000 usd
CY2023Q4 fthm Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
3467000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
386000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
381000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
26317000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
24024000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20838420 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20838420 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
129444000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126820000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77513000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71586000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
51931000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
59140000 usd
CY2024Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
8731000 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
8602000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20671515 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20671515 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
55234000 usd
CY2023Q1 fthm Operations And Support Expense
OperationsAndSupportExpense
1614000 usd
CY2024Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1950000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78248000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79258000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70503000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77541000 usd
CY2024Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
61167000 usd
CY2023Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
69172000 usd
CY2024Q1 fthm Operations And Support Expense
OperationsAndSupportExpense
2109000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
83087000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5653000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5546000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-105000 usd
CY2023Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1579000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9602000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9312000 usd
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
600000 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
715000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
728000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
695000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
76156000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-152000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-257000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-143000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5910000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5689000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5927000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5701000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19178474 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16011068 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19178474 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16011068 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
55234000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2652000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
28000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5927000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
51931000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
62021000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2820000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5701000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-5927000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5701000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1480000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1357000 usd
CY2024Q1 fthm Non Cash Lease Expense
NonCashLeaseExpense
529000 usd
CY2023Q1 fthm Non Cash Lease Expense
NonCashLeaseExpense
337000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
1215000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
831000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2652000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2820000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-356000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
336000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
901000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-202000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-8000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
434000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
644000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1112000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
411000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-566000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-374000 usd
CY2024Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
49598000 usd
CY2023Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
37179000 usd
CY2024Q1 fthm Proceeds From Sale And Principal Of Mortgage Loan Held For Sale
ProceedsFromSaleAndPrincipalOfMortgageLoanHeldForSale
50684000 usd
CY2023Q1 fthm Proceeds From Sale And Principal Of Mortgage Loan Held For Sale
ProceedsFromSaleAndPrincipalOfMortgageLoanHeldForSale
37083000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23080000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-947000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1570000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
534000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
579000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-535000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-588000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
148000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
318000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
49440000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
29826000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
49277000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
28929000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
83000 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
28000 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-96000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
579000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1578000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1579000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7540000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8380000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5962000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6801000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
90000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11000 usd
CY2024Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1284000 usd
CY2023Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
4000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5682000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6723000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
280000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
78000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5962000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6801000 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Certain Significant Risks and Business Uncertainties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The Company is subject to the risks and challenges associated with companies at a similar stage of development. These include dependence on key individuals, successful development and marketing of its offerings, and competition with larger companies with greater financial, technical, and marketing resources. Furthermore, during the period required to achieve higher revenue in order to become consistently profitable, the Company may require additional funds that might not be readily available or might not be on terms that are acceptable to the Company.</span></div>
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5900000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5700000 usd
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3300000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5700000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7400000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The preparation of the unaudited interim consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions, including those related to doubtful accounts, legal contingencies, income taxes, deferred tax asset valuation allowances, stock-based compensation, goodwill, estimated lives of intangible assets, and intangible asset impairment. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company might differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></div>
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37275000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14195000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23080000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
36741000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12832000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23909000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4159000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
5301000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
4665000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
3665000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
2525000 usd
CY2024Q1 fthm Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
2765000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
25607000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
25607000 usd
CY2024Q1 fthm Deferred Annual Fees Current
DeferredAnnualFeesCurrent
1162000 usd
CY2023Q4 fthm Deferred Annual Fees Current
DeferredAnnualFeesCurrent
948000 usd
CY2024Q1 fthm Due To Sellers
DueToSellers
405000 usd
CY2023Q4 fthm Due To Sellers
DueToSellers
488000 usd
CY2024Q1 fthm Accrued Compensation And Other Employer Cost
AccruedCompensationAndOtherEmployerCost
1367000 usd
CY2023Q4 fthm Accrued Compensation And Other Employer Cost
AccruedCompensationAndOtherEmployerCost
526000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
776000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
719000 usd
CY2024Q1 fthm Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
3710000 usd
CY2023Q4 fthm Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
2681000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4000000 usd
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
240100 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.00
CY2024Q1 fthm Number Of Underwriters Warrants Exercised Or Expired
NumberOfUnderwritersWarrantsExercisedOrExpired
0 shares
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
3736000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
3883000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
246000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
416000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3490000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3467000 usd
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
10000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Existence Of Residual Value Guarantee
LesseeOperatingLeaseExistenceOfResidualValueGuarantee
false
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
413000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
460000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
175000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
161000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
588000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
621000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0737
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0633
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1430000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1703000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1291000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1176000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
923000 usd
CY2024Q1 fthm Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
849000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7372000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1235000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
6137000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2652000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2820000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5927000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5927000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5701000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5701000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19178474 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19178474 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16011068 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16011068 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000.00 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000.00 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70503000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77541000 usd
CY2024Q1 fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-1521000 usd
CY2023Q1 fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-1369000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2652000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2820000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1480000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1357000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-257000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-143000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5927000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5701000 usd
CY2024Q1 fthm Cash Balance Commitment Amount
CashBalanceCommitmentAmount
3600000 usd
CY2023Q4 fthm Cash Balance Commitment Amount
CashBalanceCommitmentAmount
1400000 usd

Files In Submission

Name View Source Status
0001628280-24-022767-index-headers.html Edgar Link pending
0001628280-24-022767-index.html Edgar Link pending
0001628280-24-022767.txt Edgar Link pending
0001628280-24-022767-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fthm-20240331.htm Edgar Link pending
fthm-20240331.xsd Edgar Link pending
fthm-20240331xex311.htm Edgar Link pending
fthm-20240331xex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
fthm-20240331_cal.xml Edgar Link unprocessable
fthm-20240331_def.xml Edgar Link unprocessable
fthm-20240331_lab.xml Edgar Link unprocessable
fthm-20240331_pre.xml Edgar Link unprocessable
fthm-20240331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable